| Literature DB >> 33156868 |
Dong Eun Lee1, Hyun Wook Ryoo2, Sungbae Moon2, Jeong Ho Park3, Sang Do Shin3.
Abstract
Improving outcomes after out-of-hospital cardiac arrests (OHCAs) requires an integrated approach by strengthening the chain of survival and emergency care systems. This study aimed to identify the change in outcomes over a decade and effect of citywide intervention on good neurologic outcomes after OHCAs in Daegu. This is a before- and after-intervention study to examine the association between the citywide intervention to improve the chain of survival and outcomes after OHCA. The primary outcome was a good neurologic outcome, defined as a cerebral performance category score of 1 or 2. After dividing into 3 phases according to the citywide intervention, the trends in outcomes after OHCA by primary electrocardiogram rhythm were assessed. Logistic regression analysis was used to analyze the association between the phases and outcomes. Overall, 6203 patients with OHCA were eligible. For 10 years (2008-2017), the rate of survival to discharge and the good neurologic outcomes increased from 2.6% to 8.7% and from 1.5% to 6.6%, respectively. Especially for patients with an initial shockable rhythm, these changes in outcomes were more pronounced (survival to discharge: 23.3% in 2008 to 55.0% in 2017, good neurologic outcomes: 13.3% to 46.0%). Compared with phase 1, the adjusted odds ratio (AOR) and 95% confidence intervals (CI) for good neurologic outcomes was 1.20 (95% CI: 0.78-1.85) for phase 2 and 1.64 (1.09-2.46) for phase 3. For patients with an initial shockable rhythm, the AOR for good neurologic outcomes was 3.76 (1.88-7.52) for phase 2 and 5.51 (2.77-10.98) for phase 3. Citywide improvement was observed in the good neurologic outcomes after OHCAs of medical origin, and the citywide intervention was significantly associated with better outcomes, particularly in those with initial shockable rhythm.Entities:
Year: 2020 PMID: 33156868 PMCID: PMC7647071 DOI: 10.1371/journal.pone.0241804
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Citywide interventions according to study phase.
| Intervention level | Phase 2 (2012–2014) | Phase 3 (2015–2017) |
|---|---|---|
| Community | Mandatory CPR and AED training for designated first responders | Mandatory CPR and AED training for designated first responders |
| Public access defibrillation program | ||
| Prehospital EMS | DA-CPR program | Team CPR program |
| Assign a medical director | Dual-dispatch system | |
| Hospital treatment | Standardized guidelines for post-cardiac arrest treatment | |
| Education programs for emergency physicians, residents and nurses | ||
| Link of emergency care system | Establishment and action of Daegu Emergency Medical Collaboration Committee | Regional OHCA Registry |
| Public report and feedback to provinces, hospitals and EMTs |
Abbreviations: CPR, cardiopulmonary resuscitation; OHCA, out-of-hospital cardiac arrest; AED, automated external defibrillator; DA-CPR, dispatcher-assisted cardiopulmonary resuscitation; EMT, emergency medical technician; EMS, emergency medical services.
Fig 1Patient flow diagram.
Characteristics of the study population according to the intervention phase.
| Variable | All | Phase 1 | Phase 2 | Phase 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | ||||
| 6203 | 100.0 | 2124 | 100.0 | 1861 | 100.0 | 2218 | 100.0 | ||||
| 0.407 | 0.042 | 0.213 | |||||||||
| | 2026 | 32.7 | 688 | 32.4 | 580 | 31.2 | 758 | 34.2 | |||
| | 4177 | 67.3 | 1436 | 67.6 | 1281 | 68.8 | 1460 | 65.8 | |||
| 0.153 | 0.011 | <0.001 | |||||||||
| | 3642 | 58.7 | 1186 | 55.8 | 1081 | 58.1 | 1375 | 62.0 | |||
| | 2561 | 41.3 | 938 | 44.2 | 780 | 41.9 | 843 | 38.0 | |||
| 69 [55–78] | 67 [53–76] | 69 [56–77] | 71 [57–79] | 0.001 | 0.002 | <0.001 | |||||
| | 1301 | 21.0 | 329 | 15.5 | 430 | 23.1 | 542 | 24.4 | <0.001 | 0.321 | <0.001 |
| | 951 | 15.3 | 217 | 10.2 | 286 | 15.4 | 448 | 20.2 | <0.001 | <0.001 | <0.001 |
| | 1907 | 30.7 | 486 | 22.9 | 628 | 33.7 | 793 | 35.8 | <0.001 | 0.180 | <0.001 |
| | 578 | 9.3 | 147 | 6.9 | 186 | 10.0 | 245 | 11.0 | <0.001 | 0.277 | <0.001 |
| 0.280 | <0.001 | 0.073 | |||||||||
| | 1093 | 17.6 | 367 | 17.3 | 313 | 16.8 | 413 | 18.6 | |||
| | 4425 | 71.3 | 1518 | 71.5 | 1308 | 70.3 | 1599 | 72.1 | |||
| | 685 | 11.0 | 239 | 11.3 | 240 | 12.9 | 206 | 9.3 | |||
| <0.001 | <0.001 | <0.001 | |||||||||
| | 633 | 10.2 | 107 | 5.0 | 261 | 14.0 | 265 | 11.9 | |||
| | 541 | 8.7 | 106 | 5.0 | 134 | 7.2 | 301 | 13.6 | |||
| | 5029 | 81.1 | 1911 | 90.0 | 1466 | 78.8 | 1652 | 74.5 | |||
| 3016 | 48.6 | 1038 | 48.9 | 852 | 45.8 | 1126 | 50.8 | 0.051 | 0.002 | 0.212 | |
| 927 | 14.9 | 98 | 4.6 | 218 | 11.7 | 611 | 27.5 | <0.001 | <0.001 | <0.001 | |
| 15 | 0.2 | N/A | N/A | 8 | 0.4 | 7 | 0.3 | 0.548 | |||
| 1367 | 22.0 | N/A | N/A | 409 | 22.0 | 958 | 43.2 | <0.001 | |||
| 6 [5–8] | 5 [4–7] | 6 [5–8] | 6 [5–8] | <0.001 | 0.500 | 0.006 | |||||
| 10 [7–14] | 7 [5–10] | 9 [7–12] | 13 [10–17] | <0.001 | <0.001 | <0.001 | |||||
| 6 [4–9] | 5 [3–8] | 6 [4–9] | 6 [4–10] | <0.001 | 0.559 | <0.001 | |||||
| <0.001 | <0.001 | <0.001 | |||||||||
| | 4737 | 76.4 | 1220 | 57.4 | 1445 | 77.6 | 2072 | 93.4 | |||
| | 1389 | 22.4 | 866 | 40.8 | 383 | 20.6 | 140 | 6.3 | |||
| | 77 | 1.2 | 38 | 1.8 | 33 | 1.8 | 6 | 0.3 | |||
| <0.001 | <0.001 | <0.001 | |||||||||
| | 150 | 2.4 | 20 | 0.9 | 110 | 5.9 | 20 | 0.9 | |||
| | 4031 | 65.0 | 1745 | 82.2 | 1277 | 68.6 | 1009 | 45.5 | |||
| | 2022 | 32.6 | 359 | 16.9 | 474 | 25.5 | 1189 | 53.6 | |||
| 987 | 15.9 | N/A | N/A | 458 | 24.6 | 529 | 23.9 | 0.572 | |||
| <0.001 | <0.001 | <0.001 | |||||||||
| | 359 | 5.8 | 19 | 0.9 | 32 | 1.7 | 308 | 13.9 | |||
| | 1440 | 23.2 | 87 | 4.1 | 221 | 11.9 | 1132 | 51.0 | |||
| | 3171 | 51.1 | 1382 | 65.1 | 1156 | 62.1 | 633 | 28.5 | |||
| | 1233 | 19.9 | 636 | 29.9 | 452 | 24.3 | 145 | 6.5 | |||
| 78 | 1.3 | N/A | N/A | 1 | 0.1 | 77 | 3.5 | <0.001 | |||
| 1513 | 24.4 | N/A | N/A | N/A | N/A | 1513 | 68.2 | ||||
| <0.001 | <0.001 | <0.001 | |||||||||
| | 882 | 14.2 | 301 | 14.2 | 257 | 13.8 | 324 | 14.6 | |||
| | 4225 | 68.1 | 1209 | 56.9 | 1274 | 68.5 | 1742 | 78.5 | |||
| | 766 | 12.3 | 405 | 19.1 | 237 | 12.7 | 124 | 5.6 | |||
| | 330 | 5.3 | 209 | 9.8 | 93 | 5.0 | 28 | 1.3 | |||
| | 234 | 3.8 | 41 | 1.9 | 63 | 3.4 | 130 | 5.9 | 0.004 | <0.001 | <0.001 |
| | 80 | 1.3 | 8 | 0.4 | 30 | 1.6 | 42 | 1.9 | <0.001 | 0.496 | <0.001 |
| | 34 | 0.5 | 2 | 0.1 | 16 | 0.9 | 16 | 0.7 | <0.001 | 0.618 | 0.001 |
| 372 | 6.0 | 45 | 2.1 | 123 | 6.6 | 204 | 9.2 | <0.001 | 0.002 | <0.001 | |
| 372 | 6.0 | 82 | 3.9 | 126 | 6.8 | 164 | 7.4 | <0.001 | 0.440 | <0.001 | |
| 259 | 4.2 | 46 | 2.2 | 86 | 4.6 | 127 | 5.7 | <0.001 | 0.114 | <0.001 | |
Abbreviations: IQR, interquartile range; OHCA, out-of-hospital cardiac arrest; ECG, electrocardiogram; CPR, cardiopulmonary resuscitation; AED, automated external defibrillator; DA-CPR, dispatcher-assisted cardiopulmonary resuscitation; EMT, emergency medical technician; ETI, endotracheal intubation; SGA, supraglottic airway; BVM, bag valve mask; PV, passive ventilation; ED, emergency department; PCI, percutaneous coronary intervention; TTM, target temperature management; ECMO, extracorporeal membrane oxygenation; ROSC, return of spontaneous circulation.
aTime from call to arrival of the ambulance at the scene.
bTime from arrival of the ambulance at the scene to departure from the scene.
cTime from departure of the ambulance from the scene to arrival at the ED.
dP value between phase 1, and phase 2 groups.
eP value between phase 2, and phase 3 groups.
fP value between phase 3, and phase 1 groups.
Fig 2Trend of good neurologic outcome (A) and survival to discharge (B) according to primary ECG rhythm, Daegu, 2008–2017.
OHCA, out-of-hospital cardiac arrest.
Fig 3Trend in the interventions in patients with out-of-hospital cardiac arrest of medical origin in Daegu according to year.
CPR, cardiopulmonary resuscitation; DA-CPR, dispatcher-assisted CPR.
Multivariable logistic regression analysis for outcomes of study phase.
| Group | Good CPC | Survival to discharge | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No./ Total no. | % | AOR | 95% CI | No./ Total no. | % | AOR | 95% CI | |||
| 259/6203 | 4.2 | 372/6203 | 6.0 | |||||||
| Phase 1 | 46/2124 | 2.2 | Reference | 82/2124 | 3.9 | Reference | ||||
| Phase 2 | 86/1861 | 4.6 | 2.36 | 1.63 | 3.43 | 126/1861 | 6.8 | 1.88 | 1.40 | 2.52 |
| Phase 3 | 127/2218 | 5.7 | 3.11 | 2.18 | 4.43 | 1164/2218 | 7.4 | 2.14 | 1.61 | 2.84 |
| 259/6203 | 4.2 | 372/6203 | 6.0 | |||||||
| Phase 1 | 46/2124 | 2.2 | Reference | 82/2124 | 3.9 | Reference | ||||
| Phase 2 | 86/1861 | 4.6 | 1.20 | 0.78 | 1.85 | 1236/1861 | 6.8 | 1.10 | 0.78 | 1.54 |
| Phase 3 | 127/2218 | 5.7 | 1.64 | 1.09 | 2.46 | 1164/2218 | 7.4 | 1.23 | 0.89 | 1.71 |
AOR, adjusted odds ratio; CI, confidence interval; CPC, cerebral performance category.
Model 1: Adjusted for age, sex, and comorbidity (diabetes, heart disease, hypertension and stroke).
Model 2: Adjusted for age, sex, comorbidity (diabetes, heart disease, hypertension and stroke), location of arrest, primary electrocardiogram, witness status and response time interval.
Subgroup analysis for comparison of outcome by study phase according to primary ECG rhythm.
| Group | Good CPC | Survival to discharge | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No./ Total no. | % | AOR | 95% CI | No./ Total no. | % | AOR | 95% CI | |||
| 195/633 | 30.8 | 245/633 | 38.7 | |||||||
| Phase 1 | 12/107 | 11.2 | Reference | 20/107 | 18.7 | Reference | ||||
| Phase 2 | 76/261 | 29.1 | 3.05 | 1.54 | 6.01 | 100/261 | 38.3 | 2.41 | 1.37 | 4.24 |
| Phase 3 | 107/265 | 40.4 | 4.99 | 2.54 | 9.81 | 125/265 | 47.2 | 3.40 | 1.93 | 5.99 |
| 195/633 | 30.8 | 245/633 | 38.7 | |||||||
| Phase 1 | 12/107 | 11.2 | Reference | 20/107 | 18.7 | Reference | ||||
| Phase 2 | 76/261 | 29.1 | 3.76 | 1.88 | 7.52 | 100/261 | 38.3 | 3.12 | 1.74 | 5.57 |
| Phase 3 | 107/265 | 40.4 | 5.51 | 2.77 | 10.98 | 125/265 | 47.2 | 3.94 | 2.21 | 7.05 |
| 64/5570 | 1.1 | 127/5570 | 2.3 | |||||||
| Phase 1 | 34/2017 | 1.7 | Reference | 62/2017 | 3.1 | Reference | ||||
| Phase 2 | 10/1600 | 0.6 | 0.37 | 0.18 | 0.76 | 26/1600 | 1.6 | 0.51 | 0.32 | 0.82 |
| Phase 3 | 20/1953 | 1.0 | 0.63 | 0.36 | 1.12 | 39/1953 | 2.0 | 0.65 | 0.43 | 0.98 |
| 64/5570 | 1.1 | 127/5570 | 2.3 | |||||||
| Phase 1 | 34/2017 | 1.7 | Reference | 62/2017 | 3.1 | Reference | ||||
| Phase 2 | 10/1600 | 0.6 | 0.47 | 0.23 | 0.99 | 26/1600 | 1.6 | 0.63 | 0.39 | 1.021 |
| Phase 3 | 20/1953 | 1.0 | 0.73 | 0.41 | 1.33 | 39/1953 | 2.0 | 0.73 | 0.47 | 1.12 |
Abbreviations: ECG, electrocardiogram; AOR, adjusted odds ratio; CI, confidence interval; CPC, cerebral performance category.
Model 1: Adjusted for age, sex, and comorbidity (diabetes, heart disease, hypertension and stroke).
Model 2: Adjusted for age, sex, comorbidity (diabetes, heart disease, hypertension and stroke), location of arrest, witness status and response time interval.